The new approval that came from the USFDA makes it sure that the Linzess is safe and effective, bringing a sense of relief ...

The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...

The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

"Former blockbuster Linzess grows label with paediatric IBS-C approval" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...

Ibsrela (tenapanor) is a prescription drug used to treat irritable bowel syndrome with constipation (IBS-C) in adults. Ibsrela comes as an oral tablet. To learn more about Ibsrela’s uses, see the ...

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.

The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...

Irritable bowel syndrome (IBS) is a chronic condition that can cause a number of unpleasant digestive symptoms, most notably constipation or diarrhea with abdominal pain. "Gas, cramping and food ...

Fiber is a must for regular bowel movements. But if you have irritable bowel syndrome with constipation (IBS-C), you might worry that filling up on fiber could worsen symptoms such as cramps, gas, and ...

You’ve heard of IBS. You may even be a card-carrying member of the #hotgirlshaveIBS club. But what is IBS, exactly? IBS stands for irritable bowel syndrome and it’s a common disorder that affects the ...